Celgene Corp (CELG) 88.86 $CELG
Midday Glance: Biotechnology companies
AP - Mon Jul 07, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Early Glance: Biotechnology companies
AP - Mon Jul 07, 9:38AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
The 4 Most Important S&P 500 Stocks of the Past 16 Years
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jul 05, 2:30PM CDT
The S&P 500 has languished in the shadow of the Dow Jones Industrials recently, with all the hype surrounding Dow 17,000 hiding the fact that the S&P is nearing a more important milestone of its own. With this week's gains, the S&P...
Spectrum lymphoma drug OK'd
at Investor's Business Daily - Thu Jul 03, 6:00PM CDT
The FDA said it had approved Spectrum Pharmaceutical's (SPPI) drug Beleodaq for patients with peripheral T-cell lymphoma. PTCL is a rare and progressive form of non-Hodgkin lymphoma, representing 10%-15% of all cases, the FDA said. The agency noted...
Final Glance: Biotechnology companies
AP - Thu Jul 03, 4:15PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Spectrum Pharma Lymphoma Drug Approved Early
at Investor's Business Daily - Thu Jul 03, 12:14PM CDT
The FDA said Thursday that it had approved Spectrum Pharmaceuticals' (SPPI) drug Beleodaq for patients with peripheral T-cell lymphoma (PTCL), sending Spectrum's stock up as much as 6.3% early Thursday. Spectrum was up more than 1%, near 8.80, in...
Shares of CELG Up 21.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 03, 9:21AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 2 months, Celgene has returned 21.54% as of today's recent price of $89.86.
Stock Market News for July 02, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 9:06AM CDT
Benchmarks started the second half of 2014 on a positive note after economic data showed manufacturing activity picked up in U.S and Asia
Jim Cramer's Top Stock Picks: CELG GSAT FCX SBUX
at The Street - Wed Jul 02, 5:00AM CDT
Celgene is a winner and Starbucks deserves its premium multiple, Cramer says.
'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.
Jim Cramer's 'Mad Money' Recap: Strong Stocks for Another Strong Quarter
at The Street - Tue Jul 01, 7:19PM CDT
Today's record highs prove there are broad themes at work and next quarter's profits will be better than expected, Cramer asserts.
Today's Momo Momentum Stock To Watch: Celgene (CELG)
at The Street - Tue Jul 01, 8:50AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014
Business Wire - Tue Jul 01, 7:31AM CDT
Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, July 24, 2014 at 9 a.m. ET to discuss second quarter 2014 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.
Chipotle, Keurig Near Buy Points; Energy Dominates
at Investor's Business Daily - Mon Jun 30, 6:00PM CDT
Oil and gas plays make up more than half of this week's Big Cap 20 list -- yet again. No surprises there, given high worldwide demand for fuel and the continuing turmoil in Iraq. As a result, all the energy stocks making the cut are well extended...
Gilead Sciences and Celgene Corporation Have Great Growth Potential
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jun 30, 3:45PM CDT
Credit: e-Magine Art via Flickr. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some health care and biotech stocks to your portfolio but don't have the time or expertise to...
Midday Glance: Biotechnology companies
AP - Mon Jul 07, 12:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.:
Early Glance: Biotechnology companies
AP - Mon Jul 07, 9:38AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
The 4 Most Important S&P 500 Stocks of the Past 16 Years
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jul 05, 2:30PM CDT
The S&P 500 has languished in the shadow of the Dow Jones Industrials recently, with all the hype surrounding Dow 17,000 hiding the fact that the S&P is nearing a more important milestone of its own. With this week's gains, the S&P...
Spectrum lymphoma drug OK'd
at Investor's Business Daily - Thu Jul 03, 6:00PM CDT
The FDA said it had approved Spectrum Pharmaceutical's (SPPI) drug Beleodaq for patients with peripheral T-cell lymphoma. PTCL is a rare and progressive form of non-Hodgkin lymphoma, representing 10%-15% of all cases, the FDA said. The agency noted...
Final Glance: Biotechnology companies
AP - Thu Jul 03, 4:15PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Spectrum Pharma Lymphoma Drug Approved Early
at Investor's Business Daily - Thu Jul 03, 12:14PM CDT
The FDA said Thursday that it had approved Spectrum Pharmaceuticals' (SPPI) drug Beleodaq for patients with peripheral T-cell lymphoma (PTCL), sending Spectrum's stock up as much as 6.3% early Thursday. Spectrum was up more than 1%, near 8.80, in...
Shares of CELG Up 21.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 03, 9:21AM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 2 months, Celgene has returned 21.54% as of today's recent price of $89.86.
Stock Market News for July 02, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 9:06AM CDT
Benchmarks started the second half of 2014 on a positive note after economic data showed manufacturing activity picked up in U.S and Asia
Jim Cramer's Top Stock Picks: CELG GSAT FCX SBUX
at The Street - Wed Jul 02, 5:00AM CDT
Celgene is a winner and Starbucks deserves its premium multiple, Cramer says.
'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.
Jim Cramer's 'Mad Money' Recap: Strong Stocks for Another Strong Quarter
at The Street - Tue Jul 01, 7:19PM CDT
Today's record highs prove there are broad themes at work and next quarter's profits will be better than expected, Cramer asserts.
Today's Momo Momentum Stock To Watch: Celgene (CELG)
at The Street - Tue Jul 01, 8:50AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014
Business Wire - Tue Jul 01, 7:31AM CDT
Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio webcast on Thursday, July 24, 2014 at 9 a.m. ET to discuss second quarter 2014 financial and operational results. The webcast can be accessed from the Investor Relations page at www.celgene.com.
Chipotle, Keurig Near Buy Points; Energy Dominates
at Investor's Business Daily - Mon Jun 30, 6:00PM CDT
Oil and gas plays make up more than half of this week's Big Cap 20 list -- yet again. No surprises there, given high worldwide demand for fuel and the continuing turmoil in Iraq. As a result, all the energy stocks making the cut are well extended...
Gilead Sciences and Celgene Corporation Have Great Growth Potential
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jun 30, 3:45PM CDT
Credit: e-Magine Art via Flickr. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some health care and biotech stocks to your portfolio but don't have the time or expertise to...
